- The key vendors in the Global Erectile Dysfunction Drugs Market 2014-2018 are Apricus Biosciences Inc., Bayer AG, Dong-A Socio Holdings Co. Ltd., Eli Lily & Co., Pfizer Inc. and Vivus Inc.
London, 03 September 2014: TechNavio, an independent tech-focused global research firm, announced today the publication of its market research report on the Global Erectile Dysfunction Drugs Market 2014-2018. One such trend is an increase in awareness of erectile dysfunction. The acceptability of erectile dysfunction drugs is expected to increase owing to increasing public awareness about erectile dysfunction and the need to treat it.
“The number of patients with erectile dysfunction is increasing every day owing to the increase in unhealthy lifestyles. Such situation is expected to boost the growth of the market in the near future,” says Faisal Ghaus, Vice President of TechNavio Research.
“The Global Erectile Dysfunction Drugs market is experiencing increased focus on generic drugs in the treatment of erectile dysfunction. Various brand drugs such as Viagra and Cialis are used for the treatment of erectile dysfunction.”
To define the market conditions in the next 3-4 years, TechNavio analysts have conducted in-depth analysis of the impact of market drivers, challenges and trends featuring data on product segmentations, vendor shares, growth rate by revenue and an evaluation of the different buying criteria in the order of importance.
https://www.technavio.com/%3Cp%3EIf%20you%20are%20interested%20in%20more%…
